BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 12671958)

  • 1. High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy.
    Vural M; Ozekmekçi S; Apaydin H; Altinel A
    Mov Disord; 2003 Apr; 18(4):457-9. PubMed ID: 12671958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physostigmine in treatment of cerebellar ataxia].
    Aschoff JC; Kailer NA; Walter K
    Nervenarzt; 1996 Apr; 67(4):311-8. PubMed ID: 8684510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of piracetam on ataxia: clinical observations in a group of autosomal dominant cerebellar ataxia patients.
    Ince Gunal D; Agan K; Afsar N; Borucu D; Us O
    J Clin Pharm Ther; 2008 Apr; 33(2):175-8. PubMed ID: 18315783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of myoclonus in SCA2 by piracetam.
    De Rosa A; Striano P; Barbieri F; de Falco A; Rinaldi C; Tucci T; Striano S; Filla A; De Michele G
    Mov Disord; 2006 Jan; 21(1):116-8. PubMed ID: 16149096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autosomal recessive hereditary cortical cerebellar atrophy with striatal degeneration--two siblings showing choreoathetoid movement, ataxia, dementia, and amenorrhea].
    Iwabuchi K; Nakazawa Y; Akai J; Yagishita S; Amano N
    No To Shinkei; 1994 Jun; 46(6):563-71. PubMed ID: 8068439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group.
    Ikeda A; Shibasaki H; Tashiro K; Mizuno Y; Kimura J
    Mov Disord; 1996 Nov; 11(6):691-700. PubMed ID: 8914096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial occurrence of hypothyroidism and cerebellar ataxia.
    Bonuccelli U; Nuti A; Monzani F; De Negri F; Muratorio A
    Funct Neurol; 1991; 6(2):171-5. PubMed ID: 1916458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study.
    Gazulla J; Errea JM; Benavente I; Tordesillas CJ
    Eur Neurol; 2004; 52(1):7-11. PubMed ID: 15218338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: cerebellar atrophy, multiphasic relapses, and response to IVIG.
    Pranzatelli MR; Tate ED; Kinsbourne M; Caviness VS; Mishra B
    Mov Disord; 2002 Nov; 17(6):1387-90. PubMed ID: 12465092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Olivopontocerebellar atrophy as an important differential diagnosis in atactic gait disorders in elderly patients].
    Waespe W; Hayek J; Wichmann W; Bader JP
    Schweiz Med Wochenschr; 1988 Jul; 118(27-28):1032-8. PubMed ID: 3166204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A refined evaluation of cerebellar ataxia and its application to treatment of spinocerebellar degeneration].
    Takayanagi T
    Rinsho Shinkeigaku; 1993 Dec; 33(12):1297-9. PubMed ID: 8174329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hashimoto's encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration.
    Matsunaga A; Ikawa M; Fujii A; Nakamoto Y; Kuriyama M; Yoneda M
    Eur Neurol; 2013; 69(1):14-20. PubMed ID: 23128836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vecuronium in a patient with late cerebellar cortical atrophy.
    Oikawa M; Nitahara K; Shono S; Sakuragi T; Higa K
    J Clin Anesth; 2006 Mar; 18(2):145-7. PubMed ID: 16563336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure cerebello-olivary degeneration of Marie, Foix, and Alajouanine presenting with progressive cerebellar ataxia, cognitive decline, and chorea.
    Fox SH; Nieves A; Bergeron C; Lang AE
    Mov Disord; 2003 Dec; 18(12):1550-4. PubMed ID: 14673899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The cerebellar cortical atrophy syndrome].
    Ponomareva EN; Astapenko AV; Likhachev SA; Ovsiankina GI; Pashko GV; Antonenko AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(9):14-9. PubMed ID: 9410595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paroxysmal cerebellar ataxia--an evaluation using the findings from magnetic resonance imaging, positron emission tomography, and acetazolamide treatment].
    Araki S; Kawamura M; Shiota J; Isono O; Hirayama K
    Rinsho Shinkeigaku; 1990 Apr; 30(4):416-9. PubMed ID: 2387111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnetic resonance imaging in spinocerebellar degenerative diseases (apropos of 8 cases)].
    Nicolau A; Diard F; Fontan D; Chateil JF; Kien P
    Pediatrie; 1987; 42(5):359-65. PubMed ID: 3481070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late cortical cerebellar atrophy].
    Takiyama Y; Nakano I
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):247-50. PubMed ID: 10434643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Buspirone chlorhydrate in the treatment of cerebellar ataxia].
    Andrade-Filho AS; Passos-Almeida J; Andrade-Souza VM; Sena-Pereira LR
    Rev Neurol; 2002 Aug 16-31; 35(4):301-5. PubMed ID: 12235556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinocerebellar degenerations--clinical aspects and new treatment of ataxia.
    Sobue I
    Jpn J Med; 1985 Feb; 24(1):62-7. PubMed ID: 3923240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.